晚期喘反应部分独立于早期喘反应
Stefan Zielen1,2, Oguzhan Alemdar1,2, Andreas Wimmers1,2
1Department of Pediatrics, Division of Pneumology, Allergology, Infectious Diseases and Gastroenterology, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany.
International journal of molecular sciences
|March 13, 2025
概括
一些家庭灰尘 (HDM) 过敏喘患者可以在没有早期喘反应 (EAR) 的情况下经历晚期喘反应 (LAR). 这种孤立的LAR表明显著的炎症和肺功能下降的风险增加.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 呼吸系统医学 呼吸系统医学
- 分子生物学分子生物学
背景情况:
- 家庭灰尘 (HDM) 过敏是过敏性喘的主要原因.
- 喘反应可以是早期的 (EAR) 或双重的 (EAR + LAR),LAR与更严重的症状和炎症有关.
- 在没有先前的EAR的情况下LAR的发生情况尚不清楚.
研究的目的:
- 调查晚期喘反应 (LAR) 是否可以在没有显著早期喘反应 (EAR) 的情况下独立发生.
- 在患有HDM过敏的患者中识别与孤立LAR相关的生物标志物.
主要方法:
- 在一项涉及20名患有HDM过敏的喘患者的试点研究中,三次进行了支气管过敏原挑战 (BAC),用逐渐缩小的过敏原剂量.
- 在BAC.之前和24小时后测量出口的氧化 (eNO),埃索诺菲尔和特定的微RNA (miRNA).
- 监测肺功能 (FEV1),以评估早期和晚期喘反应.
主要成果:
- 很大一部分患者 (35%) 呈现LAR而没有可检测的EAR,特别是在较低的过敏原剂量下.
- 孤立的LAR与eNO增加,肺功能降低 (FEV1) 和不同的miRNA配置文件 (miR-15a-5p,miR-15b-5p,miR-374a-p5) 相关.
- 重复的过敏原挑战显示了EAR的减少,但不是LAR,这表明了不同的机制.
结论:
- 晚期喘反应 (LAR) 可以独立于早期喘反应 (EAR),以应对低水平的室内灰尘虫过敏原暴露.
- 孤立的LAR意味着严重的呼吸道炎症,与特定的miRNA和生物标志物有关,造成喘进展和肺功能下降的风险更高.
- 这些发现强调了在喘管理中评估孤立LAR的重要性,并建议潜在的新疗法目标.
相关概念视频
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
206
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
206
01:20Asthma: Pathogenesis and Management
304
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
304
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:24Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
208
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
208